Skip to main content
DNA Labs India

COL6A3 Gene Bethlem Myopathy Type 1 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

COL6A3 Gene Bethlem Myopathy Type 1 NGS Genetic Test

Short Name: COL6A3 NGS Test

Also known as: COL6A3 Gene Mutation Test, Bethlem Myopathy Type 1 Genetic Test, Collagen VI-Related Myopathy NGS Test

COL6A3 Gene Bethlem Myopathy Type 1 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood / Extracted DNA / FTA Card Blood samples. Results in Test results are generally delivered within 3 to 4 weeks from the date the sample reaches the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify pathogenic variants in the COL6A3 gene that cause Bethlem Myopathy Type 1. It is used to confirm a clinical diagnosis, differentiate from other inherited muscle disorders, assess family history risk, and provide a basis for genetic counseling and management planning. NGS technology enables simultaneous analysis of all exons of the COL6A3 gene, offering a highly accurate and comprehensive result.

Test Code
3936
Price
₹20,000
Sample Type
Blood / Extracted DNA / FTA Card Blood
Result Time
Test results are generally delivered within 3 to 4 weeks from the date the sample reaches the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. A genetic counseling session is recommended to draw a pedigree chart of family members affected with COL6A3-related disorders. This helps in interpreting results accurately.

Method: Blood draw or FTA card blood spot

Step 2

Laboratory Analysis

A trained phlebotomist will collect a blood sample in an EDTA tube or a few drops of blood on an FTA card. The procedure is quick and minimally invasive.

Step 3

Report Delivery

No special precautions are needed after sample collection. You can resume normal activities immediately.

Timeline: Test results are generally delivered within 3 to 4 weeks from the date the sample reaches the laboratory.

Patient Instructions

1
Before the Test:No special preparation needed. However, a genetic counseling session is strongly recommended to review family history and discuss the purpose, limitations, and potential outcomes of the test.
2
During the Test:A blood sample is collected from a vein in your arm. If using an FTA card, a simple finger-prick capillary blood spot is collected. The procedure takes less than 15 minutes.
3
After the Test:You can leave immediately after sample collection. The laboratory will process the sample, and results are typically available in 3 to 4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to identify pathogenic variants in the COL6A3 gene that cause Bethlem Myopathy Type 1. It is used to confirm a clinical diagnosis, differentiate from other inherited muscle disorders, assess family history risk, and provide a basis for genetic counseling and management planning. NGS technology enables simultaneous analysis of all exons of the COL6A3 gene, offering a highly accurate and comprehensive result.

How to Prepare

  • If using blood sample: Collect in an EDTA vacutainer tube.
  • If using FTA card: Apply 2-3 drops of blood onto the designated spot and allow to air dry.
  • Do not freeze the FTA card.
  • Label the sample tube/card with patient name and date of collection.

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic testing for COL6A3 is essential for confirming Bethlem Myopathy Type 1 and providing accurate genetic counseling for affected families."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood / Extracted DNA / FTA Card Blood
ContainerEDTA tube / FTA card
Collection MethodBlood draw or FTA card blood spot
Sample Rejection Criteria:
  • Clotted blood sample
  • Hemolyzed sample
  • Insufficient sample volume
  • Improperly labeled sample

Understanding Your Results

Interpretation of this test is based on the presence or absence of pathogenic variants in the COL6A3 gene. The result helps confirm or exclude a molecular diagnosis of Bethlem Myopathy Type 1.
📊

Pathogenic

Confirms diagnosis of Bethlem Myopathy Type 1; autosomal dominant inheritance expected.

📊

Likely Pathogenic

Likely confirms diagnosis; additional evidence may be needed in some cases.

📊

Variant of Uncertain Significance (VUS)

Cannot determine clinical significance; further family studies may be helpful.

📊

Likely Benign

Unlikely to cause disease; no clinical action needed.

📊

Benign

No disease association; normal finding.

⚠️ When to Consult a Doctor:

Consult a neurologist or geneticist if you or your child experience progressive muscle weakness, joint contractures, scoliosis, or if there is a family history of Bethlem myopathy. Genetic counseling before and after the test is essential for understanding implications.

Limitations

  • NGS may not detect certain large structural rearrangements, deep intronic variants, or repeat expansions
  • Variants of unknown significance may be identified, requiring additional family segregation studies
  • Test results should be interpreted in the context of clinical presentation and family history

Risks & Considerations

  • Minor bruising or pain at the blood draw site
  • Dizziness or fainting during blood collection

Interfering Factors

  • Insufficient quantity or quality of extracted DNA
  • Sample contamination with other biological material
  • Presence of large deletions/duplications not detectable by standard NGS

Compare With Similar Tests

TestCOL6A3 Gene Bethlem Myopathy Type 1 NGS Genetic TestTraditional Sanger SequencingNGS COL6A3 Gene Test
ComparisonCOL6A3 Gene Bethlem Myopathy Type 1 NGS Genetic Test

Frequently Asked Questions

What is the cost of the COL6A3 Gene Bethlem Myopathy Type 1 NGS Genetic Test?
The test costs INR 20,000 at DNA Labs India. The price includes free home sample collection and a comprehensive genetic report.
What sample is required for this test?
The test can be performed on a blood sample collected in an EDTA tube, extracted DNA, or a few drops of blood on an FTA card.
Is fasting required before the test?
No, fasting is not required for this genetic test. You can eat and drink normally before the sample collection.
How long does it take to get the test report?
The test report is typically available within 3 to 4 weeks from the time the sample reaches the laboratory.
What conditions are caused by mutations in the COL6A3 gene?
Mutations in the COL6A3 gene are associated with Bethlem Myopathy Type 1 and also Ullrich Congenital Muscular Dystrophy, both belonging to the collagen VI-related myopathy spectrum.
How does NGS technology help in diagnosing Bethlem Myopathy Type 1?
NGS is a high-throughput sequencing method that can analyze all exons of the COL6A3 gene simultaneously, detecting pathogenic variants that cause Bethlem Myopathy Type 1 with high accuracy.
Can this test be performed on an FTA card sample?
Yes, one drop of blood on an FTA card is accepted for this test, making sample collection convenient and transport easy.
Will the test detect all types of mutations in the COL6A3 gene?
NGS detects single nucleotide variants, small insertions/deletions, and splice-site variants. However, large deletions/duplications may not be detected; supplementary testing may be needed for such variants.
Is genetic counseling provided with the test?
A pre-test genetic counseling session is recommended to draw a pedigree chart and discuss the implications. Our specialists can guide you after the test as well.
Is the test available across India?
Yes, DNA Labs India offers free home sample collection for this test in major cities including Mumbai, Delhi, Bangalore, Hyderabad, and many more across the country.
Who should consider taking this genetic test?
Individuals with symptoms of muscle weakness, joint contractures, scoliosis, or a family history of Bethlem myopathy should consider this test for accurate diagnosis.
What is the difference between Bethlem Myopathy Type 1 and other collagen VI disorders?
Bethlem Myopathy Type 1 is a milder form of collagen VI-related myopathy, while Ullrich Congenital Muscular Dystrophy is more severe. Clinical severity and age of onset help differentiate them.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.